Thromboxane A₂ receptors influenced by cell density in cultured rat aortic smooth muscle cellsMASUDA, A; HALUSHKA, P. V.Life sciences (1973). 1991, Vol 48, Num 25, pp 2391-2395, issn 0024-3205Article

Gender-related differences in androgen regulation of thromboxane A₂ receptors in rat aortic smooth-muscle cellsHIGASHIURA, K; MATHUR, R. S; HALUSHKA, P. V et al.Journal of cardiovascular pharmacology. 1997, Vol 29, Num 3, pp 311-315, issn 0160-2446Article

Molecular pharmacology and therapeutic potential of thromboxane A₂ receptor antagonistsDAVIS-BRUNO, K. L; HALUSHKA, P. V.Advances in Drug Research. 1994, Vol 25, pp 173-202, issn 0065-2490Article

Testosterone increases thromboxane A₂ receptors in cultured rat aortic smooth muscle cellsMASUDA, A; RAJESH MATHUR; HALUSHKA, P. V et al.Circulation research. 1991, Vol 69, Num 3, pp 638-643, issn 0009-7330Article

Binding of a thromboxane A₂/prostaglandin H₂ receptor antagonist to guinea-pig plateletsHALUSHKA, P. V; MAIS, D. E; GARVIN, M et al.European journal of pharmacology. 1986, Vol 131, Num 1, pp 49-54, issn 0014-2999Article

ADH or theophylline-induced changes in intracellular free and membrane-bound calciumBURCH, R. M; HALUSHKA, P. V.American journal of physiology. Renal, fluid and electrolyte physiology. 1984, Vol 16, Num 6, pp F939-F945, issn 0363-6127Article

Castration reduces platelet thromboxane A₂ receptor density and aggregabilityAJAYI, A. A. L; HALUSHKA, P. V.QJM (Oxford. 1994. Print). 2005, Vol 98, Num 5, pp 349-356, issn 1460-2725, 8 p.Article

Binding of a thromboxane A₂/prostaglandin H₂ agonist [³H]U46619 to washed human plateletsLIEL, N; MAIS, D. E; HALUSHKA, P. V et al.Prostaglandins. 1987, Vol 33, Num 6, pp 789-797, issn 0090-6980Article

Inhibition of ligand binding to thromboxane A₂/prostaglandin H₂ receptors by diethylpyrocarbonate : protection by receptor ligands and reversal by hydroxylamineSCHRÖR, K; DAVIS-BRUNO, K; HALUSHKA, P. V et al.Biochemical pharmacology. 1995, Vol 49, Num 7, pp 921-927, issn 0006-2952Article

Photoaffinity receptor antagonis for human platelet thromboxane A₂/prostaglandin H₂ receptorsMAIS, D. E; LIEL, N; HALUSHKA, P. V et al.Biochemical pharmacology. 1990, Vol 40, Num 7, pp 1457-1461, issn 0006-2952, 5 p.Article

Binding of a thromboxane A₂/prostaglandin H₂ receptor antagonist to guinea-pig plateletsHALUSHKA, P. V; MAIS, D. E; GARVIN, M et al.European journal of pharmacology. 1986, Vol 131, Num 1, pp 49-54, issn 0014-2999Article

Desensitization of platelet thromboxane A₂/prostaglandin H₂ receptors by the mimetic U46619LIEL, N; MAIS, D. E; HALUSHKA, P. V et al.The Journal of pharmacology and experimental therapeutics. 1988, Vol 247, Num 3, pp 1133-1138, issn 0022-3565Article

Verapamil inhibition of vasopressin-stimulated water flow: possible role of intracellular calciumBURCH, R. M; HALUSHKA, P. V.The Journal of pharmacology and experimental therapeutics. 1983, Vol 226, Num 3, pp 701-705, issn 0022-3565Article

Androgen regulation of thromboxane A₂/prostaglandin H₂ receptor expression in human erythroleukemia cellsMATSUDA, K; MATHUR, R. S; DUZIC, E et al.American journal of physiology. Endocrinology and metabolism. 1993, Vol 28, Num 6, pp E928-E934, issn 0193-1849Article

Different pharmacologic activities for 13-azapinane thromboxane A₂ analogs in platelets and blood vesselsMAIS, D. E; DEHOLL, D; SIGHTLER, H et al.European journal of pharmacology. 1988, Vol 148, Num 3, pp 309-315, issn 0014-2999Article

Homologous desensitization of human platelet thromboxane A₂/prostaglandin H₂ receptorsOKWU, A. K; ULLIAN, M. E; HALUSHKA, P. V et al.The Journal of pharmacology and experimental therapeutics. 1992, Vol 262, Num 1, pp 238-245, issn 0022-3565Article

Binding of thromboxane A₂/prostaglandin H₂ agonists to human plateletsHALUSHKA, P. V; KOCHEL, P. J; MAIS, D. E et al.British journal of pharmacology. 1987, Vol 91, Num 1, pp 223-227, issn 0007-1188Article

Radioligand binding assays for thromboxane A₂/prostaglandin H₂ receptorsHALUSHKA, P. V; MORINELLI, T. A; MAIS, D. E et al.Methods in enzymology. 1990, Vol 187, pp 397-405, issn 0076-6879, 9 p.Article

Prostaglandin-independent inhibition of calcium transport by nonsteroidal anti-inflammatory drugs: differential effects of carboxylic acids and piroxicamBURCH, R. M; WISE, W. C; HALUSHKA, P. V et al.The Journal of pharmacology and experimental therapeutics. 1983, Vol 227, Num 1, pp 84-91, issn 0022-3565Article

Human platelets modulate edema formation in isolated rabbit lungsHEFFNER, J. E; COOK, J. A; HALUSHKA, P. V et al.The Journal of clinical investigation. 1989, Vol 84, Num 3, pp 757-764, issn 0021-9738, 8 p.Article

Further studies on the effects of epimers of thromboxane A₂ antagonists on platelets and veinsMAIS, D. E; DUNLAP, C; HAMANAKA, N et al.European journal of pharmacology. 1985, Vol 111, Num 1, pp 125-128, issn 0014-2999Article

Interactions of dihydropyridine Ca²⁺ channel agonists with the human platelet thromboxane A₂/prostaglandin H₂ receptorMAYEUX, P. R; MAIS, D. E; HALUSHKA, P. V et al.European journal of pharmacology. 1991, Vol 206, Num 1, pp 15-21, issn 0014-2999, 7 p.Article

Characterization of the vascular thromboxane A₂/prostaglandin endoperoxide receptor in rabbit aorta : regulation by dexamethasoneSESSA, W. C; HALUSHKA, P. V; OKWU, A et al.Circulation research. 1990, Vol 67, Num 6, pp 1562-1569, issn 0009-7330, 8 p.Article

Protective effect of a selective leukotriene antagonist in endotoxemia in the ratCOOK, J. A; WISE, W. C; HALUSHKA, P. V et al.The Journal of pharmacology and experimental therapeutics. 1985, Vol 235, Num 2, pp 470-474, issn 0022-3565Article

Testosterone increases human platelet thromboxane A₂ receptor density and aggregation responsesAJAYI, A. A. L; RAJESH MATHUR; HALUSHKA, P. V et al.Circulation (New York, N.Y.). 1995, Vol 91, Num 11, pp 2742-2747, issn 0009-7322Article